Schrumpf E - Search Results

1

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. Scand J Gastroenterol. 2002 Oct;37(10):1205-11. doi: 10.1080/003655202760373434. Scand J Gastroenterol. 2002. PMID: 12408527

2

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. Hepatology. 2002 Mar;35(3):652-7. doi: 10.1053/jhep.2002.31872. Hepatology. 2002. PMID: 11870380

3

Diagnosis and treatment of cholangiocarcinoma.

Boberg KM, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. Curr Gastroenterol Rep. 2004 Feb;6(1):52-9. doi: 10.1007/s11894-004-0026-1. Curr Gastroenterol Rep. 2004. PMID: 14720454 Review.

4

No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A. Wiencke K, et al. Among authors: schrumpf e. Scand J Gastroenterol. 2006 May;41(5):586-91. doi: 10.1080/00365520500377870. Scand J Gastroenterol. 2006. PMID: 16638702

5

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

6

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

7

Genetic epidemiology of primary sclerosing cholangitis.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. World J Gastroenterol. 2007 Nov 7;13(41):5421-31. doi: 10.3748/wjg.v13.i41.5421. World J Gastroenterol. 2007. PMID: 17907284 Free PMC article. Review.

8

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA. Melum E, et al. Among authors: schrumpf e. Hepatology. 2008 Jan;47(1):90-6. doi: 10.1002/hep.21964. Hepatology. 2008. PMID: 18023027

9

Gallbladder polyps in primary sclerosing cholangitis: not so benign.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Curr Opin Gastroenterol. 2008 May;24(3):395-9. doi: 10.1097/MOG.0b013e3282f5727a. Curr Opin Gastroenterol. 2008. PMID: 18408471 Review.

10

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma.

Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjørås M, Boberg KM, Alseth I. Forsbring M, et al. Among authors: schrumpf e. Carcinogenesis. 2009 Jul;30(7):1147-54. doi: 10.1093/carcin/bgp118. Epub 2009 May 14. Carcinogenesis. 2009. PMID: 19443904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page